Article Text

Download PDFPDF
Medicines update

Statistics from

The points below highlight changes in marketing authorisations (MAs) that may have a significant impact on veterinary surgeons’ prescribing decisions.

New marketing authorisations

New marketing authorisations relevant to veterinary surgeons in the UK that were issued or published in April 2019 are listed in Table 1.

View this table:
Table 1: Marketing authorisations issued and/or published in April 2019

Of those products listed, the VMD draws attention to:

  • Arti-Cell Forte suspension for injection for horses, containing chonodrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells, indicated for the reduction of mild to moderate recurrent lameness associated with non-septic joint inflammation in horses is a novel stem cell product.

Table 1 also indicates where a public assessment report should become available for a product. Where …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.